Skip to main content
Livermore
Livermore
ZHEN

Cravens & Co Advisors, LLC

SEC CIK
0001966116
Latest filing
Aug 12, 2026

GSK holding history

GSK plc in every 13F filed by Cravens & Co Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
7,400
Value
$387.9K
% of portfolio
0.3%
Quarters held
14
Since Q4 2022
Holdings of GSK by Cravens & Co Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,400$387.9K0.3%−351−4.5%ReducedHolders
Q1 20267,751$427.8K0.3%+184+2.4%AddedHolders
Q4 20257,567$377.6K0.2%−189−2.4%ReducedHolders
Q3 20257,756$334.7K0.2%−30.0%ReducedHolders
Q2 20257,759$297.9K0.2%+170+2.2%AddedHolders
Q1 20257,589$294.0K0.2%+7,589NewHolders
Q4 20240$00.0%−7,459−100.0%Sold outHolders
Q3 20247,459$304.9K0.2%−881−10.6%ReducedHolders
Q2 20248,340$321.1K0.2%−197−2.3%ReducedHolders
Q1 20248,537$366.0K0.3%−382−4.3%ReducedHolders
Q4 20238,919$330.5K0.3%−315−3.4%ReducedHolders
Q3 20239,234$334.7K0.3%−99−1.1%ReducedHolders
Q2 20239,333$332.6K0.3%−76−0.8%ReducedHolders
Q1 20239,409$334.8K0.3%+30.0%AddedHolders
Q4 20229,406$330.5K0.3%–No prior filingHolders